Pfizer (PFE: NYSE) By MKM Partners ($29.30, May 23, 2013) We are increasing our fair-value estimate of Neutral-rated Pfizer to $29 from $28 on an earlier-than-expected Zoetis spinoff. Pfizer (ticker: PFE) expects to split off its remaining
...Table: Hedge Funds: Best-Worst-Biggest [1]
To help celebrate 15 years running a successful hedge fund, Jeff Gates decided it was OK to talk to the press for the first time.
He's got ample reason to feel chatty. His event-driven fund, ECF Value, has delivered average annualized gains of 17.5% a year since its 1996 start-up, and an average 26.27% in